Another ViewEPS was $0.05, well ahead of estimates of $0.015. Revenue of $168.2M matched estimates. EBITDA of ~$32M was 25% ahead of estimates. Free cash flow was $22.7M. Revenue rose 10%. Since June, it has bought back an impressive 2.7M shares, yet still remains net-debt free with cash at $26M. Growth is very high this year but is expected to slow to 10% next year. The stock is quite cheap at 8X earnings. There is small cap and cyclical risk here but otherwise it looks good. (5iResearch)